Lobbying disclosures · Lobbying report
WST: third_quarter 2026 lobbying report
Matters relating to the pharmaceutical manufacturing and supply chain security. Matters relating to the pharmaceutical manufacturing and supply chain security. Matters relating to the pharmaceutical manufacturing and supply chain security.
Follow WST- Became public
- Oct 19, 2026, 6:19 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 10:49 AM EST
Why this is connected
Exact legal-name match: WEST PHARMACEUTICAL SERVICES INC (https://www.sec.gov/Archives/edgar/data/105770/).
Reported lobbying amounts
Income: $20,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/24136166-b989-4643-ba22-10cf53136792/","filing_uuid":"24136166-b989-4643-ba22-10cf53136792","filing_type":"3T","filing_type_display":"3rd Quarter - Termination","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/24136166-b989-4643-ba22-10cf53136792/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Anthony Campau","dt_posted":"2026-10-19T18:19:55-04:00","termination_date":"2026-07-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 Pennsylvania Avenue NW, Suite 1300S","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401106670,"url":"https://lda.gov/api/v1/registrants/401106670/","house_registrant_id":45635,"name":"CLARK HILL PUBLIC STRATEGIES LLC","description":null,"address_1":"1001 Pennsylvania Avenue NW, Suite 1300S","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY CAMPAU","contact_telephone":"+1 240-331-8804","dt_updated":"2026-07-17T13:00:21.626343-04:00"},"client":{"id":64539,"url":"https://lda.gov/api/v1/clients/64539/","client_id":64539,"name":"WEST PHARMACEUTICAL SERVICES, INC.","general_description":"Pharmaceuticals","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-24"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155507,"prefix":null,"prefix_display":null,"first_name":"L.","nickname":null,"middle_name":"J.","last_name":"CHAVIS","suffix":null,"suffix_display":null},"covered_position":"Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17).","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155507,"prefix":null,"prefix_display":null,"first_name":"L.","nickname":null,"middle_name":"J.","last_name":"CHAVIS","suffix":null,"suffix_display":null},"covered_position":"Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17).","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155507,"prefix":null,"prefix_display":null,"first_name":"L.","nickname":null,"middle_name":"J.","last_name":"CHAVIS","suffix":null,"suffix_display":null},"covered_position":"Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17).","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in WST
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold West Pharmaceutical Services WST
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Bought West Pharmaceutical Services WST
$1K–$15K · Traded Jun 17, 2025 · disclosed Aug 13, 2025 · Spouse · filed 57 days later
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
Sold West Pharmaceutical Services WST
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
Bought West Pharmaceutical Services WST
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Mar 6, 2025$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
Sold West Pharmaceutical Services WST
$1K–$15K · Traded Feb 13, 2025 · disclosed Mar 6, 2025 · Dependent
- Dec 9, 2024$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
Sold West Pharmaceutical Services WST
$1K–$15K · Traded Nov 8, 2024 · disclosed Dec 9, 2024
- Aug 21, 2024$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
Bought West Pharmaceutical Services WST
$1K–$15K · Traded Dec 28, 2023 · disclosed Aug 21, 2024 · filed 237 days later
- Aug 21, 2024$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
Bought West Pharmaceutical Services WST
$1K–$15K · Traded Jul 14, 2023 · disclosed Aug 21, 2024 · filed 404 days later
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.